Stay updated on DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial

Sign up to get notified when there's something new on the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the lapse-in-funding notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:09:52.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status and NIH Clinical Center operations was added. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:29:04.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Minor UI and metadata updates were made: a glossary option was added and labels related to QC updates and the revision/version string were adjusted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T21:42:09.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    A new revision note 'Revision: v3.3.3' has been added, and the HHS Vulnerability Disclosure and Revision: v3.3.2 items were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-22T22:31:28.000Z thumbnail image
  6. Check
    85 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.3.1 to v3.3.2; no study content or data were changed.
    Difference
    0.0%
    Check dated 2025-12-01T12:52:30.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and v3.2.0 removed. The page content, including study details and criteria, remains unchanged.
    Difference
    0.0%
    Check dated 2025-11-24T11:32:06.000Z thumbnail image

Stay in the know with updates to DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page.